Suppr超能文献

人垂体腺瘤中的Mdm2与p53信号通路

Mdm2 and the p53 pathway in human pituitary adenomas.

作者信息

Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, Jones T H

机构信息

Department of Endocrinology, Royal Hallamshire Hospital, Sheffield, UK.

出版信息

Clin Endocrinol (Oxf). 2001 Mar;54(3):317-25. doi: 10.1046/j.1365-2265.2001.01195.x.

Abstract

OBJECTIVE

Studies on pituitary tumours have failed to identify mutations in the tumour suppressor gene p53 suggesting that the protein identified is wild type. p21(WAF--1) is a downstream effector of p53 which promotes growth arrest. Mdm2 (mouse double minute) is a protein induced by wild type p53 and forms an autoregulatory feedback loop suppressing wild type p53 activity. The purpose of this study was to examine a group of pituitary tumours for expression of p53 and its two downstream effector proteins p21(WAF--1) and mdm2 and to compare this with their radiological invasive status and proliferative potential as assessed by Ki-67 expression.

SUBJECTS AND METHODS

Sixty-nine tumours removed at transsphenoidal surgery were examined by immunocytochemistry using antibodies against p53, p21(WAF--1), mdm2 and Ki-67 (MIB-1). The invasive status of the tumours was determined from the preoperative CT/MRI scans.

RESULTS

p53 was expressed in 42 of 69 (61%) pituitary adenomas but there was no relationship with either pituitary tumour invasive status (P = 0.71) or volume (P = 0.33). p53 expression correlated, however, with the proliferative state of the tumours as assessed by the MIB-1 labelling index (P = 0.0065). Invasive tumours had a higher growth fraction than non-invasive ones (P = 0.027). p21(WAF--1) was expressed in the nuclei of 58/69 (84%) pituitary adenomas and its expression correlated with that of p53 (r = 0.26, P = 0.03). Mdm2 was expressed in the cytoplasm of 46/69 (67%) tumours and this correlated with the nuclear staining for p53 (P = 0.022) while nuclear staining was seen in 32/69 (46%) tumours but this did not correlate significantly with nuclear p53 staining (P = 0.096).

CONCLUSIONS

These results suggest that p53, p21(WAF--1) and mdm2 are all expressed in pituitary tumours suggesting that the p53 protein detected by immunocytochemistry is wild type. Expression of p53 is associated with tumours which have a higher proliferative status. The p53 activity is probably the result of upstream signals of local stresses mediated through either genetic change, cytokines, hypoxia or hormonal factors. Our results suggest, however, that the downstream pathway mediated through the activities of p21(WAF--1) and mdm2 may be dysfunctional in these tumours.

摘要

目的

对垂体瘤的研究未能发现肿瘤抑制基因p53的突变,提示所鉴定的蛋白为野生型。p21(WAF-1)是p53的下游效应分子,可促进生长停滞。Mdm2(小鼠双微体)是一种由野生型p53诱导产生的蛋白,形成一个自动调节反馈环抑制野生型p53的活性。本研究的目的是检测一组垂体瘤中p53及其两个下游效应蛋白p21(WAF-1)和Mdm2的表达,并将其与通过Ki-67表达评估的放射学侵袭状态和增殖潜能进行比较。

对象与方法

对69例经蝶窦手术切除的肿瘤进行免疫细胞化学检测,使用抗p53、p21(WAF-1)、Mdm2和Ki-67(MIB-1)的抗体。根据术前CT/MRI扫描确定肿瘤的侵袭状态。

结果

69例垂体腺瘤中有42例(61%)表达p53,但与垂体瘤的侵袭状态(P = 0.71)或体积(P = 0.33)均无相关性。然而,p53表达与通过MIB-1标记指数评估的肿瘤增殖状态相关(P = 0.0065)。侵袭性肿瘤的生长分数高于非侵袭性肿瘤(P = 0.027)。58/69(84%)例垂体腺瘤的细胞核中表达p21(WAF-1),其表达与p53表达相关(r = 0.26,P = 0.03)。46/69(67%)例肿瘤的细胞质中表达Mdm2,这与p53的细胞核染色相关(P = 0.022),而32/69(46%)例肿瘤可见细胞核染色,但与细胞核p53染色无显著相关性(P = 0.096)。

结论

这些结果提示p53、p21(WAF-1)和Mdm2在垂体瘤中均有表达,提示免疫细胞化学检测到的p53蛋白为野生型。p53表达与增殖状态较高的肿瘤相关。p53活性可能是由遗传改变、细胞因子、缺氧或激素因子介导的局部应激上游信号的结果。然而,我们的结果提示,在这些肿瘤中,通过p21(WAF-1)和Mdm2活性介导的下游途径可能功能失调。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验